DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 111 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,208,000
-64.0%
291,0050.0%0.02%
-66.7%
Q1 2022$3,352,000
-82.0%
291,005
-84.4%
0.08%
-80.8%
Q4 2021$18,637,000
-28.3%
1,867,467
-6.1%
0.39%
-22.9%
Q3 2021$25,985,000
-33.3%
1,989,6250.0%0.51%
-26.7%
Q2 2021$38,957,000
-7.9%
1,989,6250.0%0.69%
-22.2%
Q1 2021$42,319,000
-47.7%
1,989,625
-26.9%
0.89%
-44.4%
Q4 2020$80,901,000
+96.8%
2,721,203
+43.4%
1.60%
+59.7%
Q3 2020$41,109,000
-25.4%
1,897,047
-23.2%
1.00%
-37.6%
Q2 2020$55,081,000
+19.4%
2,470,013
-18.5%
1.60%
+9.6%
Q1 2020$46,140,000
-53.1%
3,031,565
-29.3%
1.46%
-53.4%
Q4 2019$98,482,000
+76.2%
4,289,291
+65.7%
3.14%
+37.9%
Q3 2019$55,903,000
+307.2%
2,589,291
+315.0%
2.28%
+362.3%
Q2 2019$13,727,000
+72.1%
623,933
+114.4%
0.49%
+61.1%
Q1 2019$7,976,000
+2.0%
291,0050.0%0.31%
-2.2%
Q4 2018$7,822,000
-26.7%
291,005
-20.4%
0.31%
-18.1%
Q3 2018$10,667,000
-51.5%
365,689
-48.0%
0.38%
-50.5%
Q2 2018$21,995,000
+89.9%
703,600
+20.9%
0.77%
+92.5%
Q1 2018$11,582,000
-31.5%
582,0100.0%0.40%
-39.8%
Q4 2017$16,913,000582,0100.67%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders